UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029059
Receipt number R000033236
Scientific Title A comparison of cerebral oxygenation as measured by the O3, the NIRO 200 and the INVOS 5100 Near-Infrared Spectrophotometers
Date of disclosure of the study information 2017/10/01
Last modified on 2023/02/08 14:47:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A comparison of cerebral oxygenation as measured by the O3, the NIRO 200 and the INVOS 5100 Near-Infrared Spectrophotometers

Acronym

A comparison of cerebral oxygenation as measured by the O3, the NIRO 200 and the INVOS 5100 Near-Infrared Spectrophotometers

Scientific Title

A comparison of cerebral oxygenation as measured by the O3, the NIRO 200 and the INVOS 5100 Near-Infrared Spectrophotometers

Scientific Title:Acronym

A comparison of cerebral oxygenation as measured by the O3, the NIRO 200 and the INVOS 5100 Near-Infrared Spectrophotometers

Region

Japan


Condition

Condition

healthy volunteers

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We aim to investigate accuracy and usability of Mashimo O3, comparing with INVOS5100C and NIRO-200NX with healthy volunteers.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Comparing with values of regional oxygen saturation(rSO2) measured by three devices

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

position with head up and head down, oxygenation, and hyperventilation

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

40 years-old >

Gender

Male and Female

Key inclusion criteria

healthy volunteers

Key exclusion criteria

disease of respiratory, heart or central nervous system

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Kaneyuki
Middle name
Last name Kawamae

Organization

Yamagata University Faculty of Medicine

Division name

Department of Anesthesiology

Zip code

9909585

Address

2-2-2, Iida-nishi, Yamagata-shi, Yamagata

TEL

023-628-5400

Email

kkawamae@med.id.yamagata-u.ac.jp


Public contact

Name of contact person

1st name Hiroto
Middle name
Last name Suzuki

Organization

Yamagata University Faculty of Medicine

Division name

Department of Anesthesiology

Zip code

9909585

Address

2-2-2, Iida-nishi, Yamagata-shi, Yamagata

TEL

023-628-5400

Homepage URL


Email

yoreyore0@med.id.yamagata-u.ac.jp


Sponsor or person

Institute

Yamagata University

Institute

Department

Personal name



Funding Source

Organization

Yamagata University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

the Ethical Review Committee of Yamagata University Faculty of Medicine

Address

2-2-2, Iida-nishi, Yamagata city, Yamagata, Japan

Tel

023-628-5047

Email

ikekenkyu@jm.kj.yamagata-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 10 Month 01 Day


Related information

URL releasing protocol

https://www.aub.edu.lb/fm/Anesthesiology/meja/Documents2/Volume28/MEJA%20No%2028%202021.pdf

Publication of results

Published


Result

URL related to results and publications

https://www.aub.edu.lb/fm/Anesthesiology/meja/Documents2/Volume28/MEJA%20No%2028%202021.pdf

Number of participants that the trial has enrolled

9

Results

The differences in baseline mean rScO2 of MASIMO O3 compared to NIRO 300 and INVOS 5100 were significantly lower (p < 0.05).
The estimates for both absolute-agreementand consistency tests for NIRO 300 and INVOS 5100 pairs were 0.74.
The estimates for NIRO 300 and MASIMO O3 pair for absolute agreement was 0.43. Estimates for INVOS 5100 and MASIMO O3 were similar to those for NIRO 300 and MASIMO O3 (absolute agreement = 0.48).

Results date posted

2023 Year 02 Month 08 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

The mean (SD) age was 27 (2) years with a range of 25 - 30 years.
The mean (SD) weight and height were 64 (10) kg and 167 (10) cm respectively, while the body mass index (BMI) ranged from 19.4 to 26.0 kg/m2 with a mean (SD) 22.5 (2.5) kg/m2.

Participant flow

With the volunteers in supine position on the operating room (OR) table, the adhesive optodes of NIRO, INVOS, and MASIMO O3 were placed sequentially one after the other on the left side of the forehead 1cm above the eyebrow and 1cm lateral to the midline. The study had 7 sequential stages with each lasting 5 minutes, followed by a 3 minute period for equilibration before the next stage (Figure 1). Each volunteer went through each of the 7 stages for each of the sensors in a sequence ofNIRO to INVOS to MASIMO. A transition period of 5 minutes for change of sensor to the next NIRS monitor was observed.
Each volunteer went through a total of 21 stages. The volunteers were instructed to
breathe normally in room air (Control-A), then 20 degrees head down, 20 degrees head up, then supine with the volunteers breathing hyperoxic gas mixtures with fraction of inspired oxygen (FiO2) of 45% followed by FiO2 of 100% administered via Drager anesthesia machine. Volunteers were returned to room air in supine position (Control-B) before they were finally instructed to hyperventilate in room air until an ETCO2 value of 22.5mmHg (3.0 kPa) was achieved for the hyperventilation stage. The angle of the OR table was standardised using a digital angle meter. Oxygen analyzer on the anaesthesia machine was used to ensure delivery of the desired oxygen concentration.
Gas delivery was through a single use disposable circle breathing system attached to a properly fitting mask.
Main streaming ETCO2 unit was connected between the HME filter and the Y-piece of the breathing system.
For each of the interventions, vital parameters were recorded over the 5 minute period.

Adverse events

nothing

Outcome measures

Data collected from each of the subjects after proper medical history for exclusion of inappropriate volunteers included demographic data (age, weight, height).
The heart rate (HR), peripheral oxygen saturation (SpO2), systolic blood pressure (SBP), diastolic blood pressure (DBP), stroke volume (SV), cardiac Index (CI) and regional cerebral oxygen
saturation (rScO2) were measured continuously after obtaining baseline values. Recordings were manually extracted and entered into the study proforma at intervals of 1 min throughout the study period.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 08 Month 15 Day

Date of IRB

2017 Year 07 Month 10 Day

Anticipated trial start date

2017 Year 08 Month 15 Day

Last follow-up date

2017 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2021 Year 08 Month 31 Day


Other

Other related information



Management information

Registered date

2017 Year 09 Month 08 Day

Last modified on

2023 Year 02 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033236


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name